Loading clinical trials...
Loading clinical trials...
Fibromyalgia is a rheumatological disorder characterised by chronic widespread body pain, second most common after osteoarthritis. The overall prevalence is 2-8% and it is more common in women. Diffus...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gaziosmanpasa Research and Education Hospital
NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more
NCT07282392 · Lupus, Fibromyalgia (FM), and more
NCT07293767 · Fibromyalgia (FM)
NCT05005897 · Vitamin B 12 Deficiency
NCT07150455 · Fibromyalgia (FM), Subclinical Ventricular Dysfunction, and more
Gaziosmanpasa Research and Education Hospital
Istanbul, Gaziosmanpasa
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions